全文获取类型
收费全文 | 1654128篇 |
免费 | 138901篇 |
国内免费 | 6393篇 |
专业分类
耳鼻咽喉 | 22105篇 |
儿科学 | 53988篇 |
妇产科学 | 46810篇 |
基础医学 | 232872篇 |
口腔科学 | 48060篇 |
临床医学 | 148476篇 |
内科学 | 321635篇 |
皮肤病学 | 34692篇 |
神经病学 | 132344篇 |
特种医学 | 66469篇 |
外国民族医学 | 500篇 |
外科学 | 248079篇 |
综合类 | 51169篇 |
现状与发展 | 8篇 |
一般理论 | 551篇 |
预防医学 | 127710篇 |
眼科学 | 37715篇 |
药学 | 128181篇 |
55篇 | |
中国医学 | 7069篇 |
肿瘤学 | 90934篇 |
出版年
2018年 | 16484篇 |
2016年 | 14528篇 |
2015年 | 17625篇 |
2014年 | 23875篇 |
2013年 | 34484篇 |
2012年 | 47269篇 |
2011年 | 49911篇 |
2010年 | 30151篇 |
2009年 | 28411篇 |
2008年 | 46509篇 |
2007年 | 48510篇 |
2006年 | 49077篇 |
2005年 | 47352篇 |
2004年 | 45923篇 |
2003年 | 43806篇 |
2002年 | 42576篇 |
2001年 | 76677篇 |
2000年 | 79180篇 |
1999年 | 67235篇 |
1998年 | 18235篇 |
1997年 | 16861篇 |
1996年 | 16690篇 |
1995年 | 16338篇 |
1994年 | 15331篇 |
1993年 | 14401篇 |
1992年 | 55630篇 |
1991年 | 53938篇 |
1990年 | 52696篇 |
1989年 | 50961篇 |
1988年 | 47313篇 |
1987年 | 46678篇 |
1986年 | 44356篇 |
1985年 | 42902篇 |
1984年 | 32073篇 |
1983年 | 27588篇 |
1982年 | 16163篇 |
1981年 | 14464篇 |
1980年 | 13583篇 |
1979年 | 30472篇 |
1978年 | 21081篇 |
1977年 | 17777篇 |
1976年 | 16704篇 |
1975年 | 17580篇 |
1974年 | 21496篇 |
1973年 | 20678篇 |
1972年 | 18854篇 |
1971年 | 17770篇 |
1970年 | 16292篇 |
1969年 | 15273篇 |
1968年 | 13951篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
Kinase alterations are increasingly recognised as oncogenic drivers in mesenchymal tumours. Infantile fibrosarcoma and the related renal tumour, congenital mesoblastic nephroma, were among the first solid tumours shown to harbour recurrent tyrosine kinase fusions, with the canonical ETV6::NTRK3 fusion identified more than 20 years ago. Although targeted testing has long been used in diagnosis, the advent of more robust sequencing techniques has driven the discovery of kinase alterations in an array of mesenchymal tumours. As our ability to identify these genetic alterations has improved, as has our recognition and understanding of the tumours that harbour these alterations. Specifically, this study will focus upon mesenchymal tumours harbouring NTRK or other kinase alterations, including tumours with an infantile fibrosarcoma-like appearance, spindle cell tumours resembling lipofibromatosis or peripheral nerve sheath tumours and those occurring in adults with a fibrosarcoma-like appearance. As publications describing the histology of these tumours increase so, too, do the variety kinase alterations reported, now including NTRK1/2/3, RET, MET, RAF1, BRAF, ALK, EGFR and ABL1 fusions or alterations. To date, these tumours appear locally aggressive and rarely metastatic, without a clear link between traditional features used in histological grading (e.g. mitotic activity, necrosis) and outcome. However, most of these tumours are amenable to new targeted therapies, making their recognition of both diagnostic and therapeutic import. The goal of this study is to review the clinicopathological features of tumours with NTRK and other tyrosine kinase alterations, discuss the most common differential diagnoses and provide recommendations for molecular confirmation with associated treatment implications. 相似文献
2.
3.
4.
5.
目的分析细棒、PEEK棒固定对寰枢关节稳定性的影响。方法采用6具新鲜成人枕骨(occipital bone,Oc)~颈椎C4节段进行测试,模拟以下手术及固定状态:①完整状态;②损伤状态:枢椎齿状突II型骨折;③坚强固定:寰枢椎均采用普通椎弓根螺钉固定,直径3.5 mm钛棒连接;④PEEK棒:直径3.5 mm的PEEK棒连接;⑤细棒:直径2.0 mm钛棒连接。采用重复测量实验设计,在完整、损伤和不同的固定状态下,通过脊柱试验机对标本分别施加1.5 N·m的前屈/后伸、左/右侧弯和左/右轴向旋转的纯力偶矩。采用Optotrak三维运动测量系统连续采集标本运动,分析寰枢椎之间角度运动范围和中性区。结果采用直径3.5 mm的钛棒,2.0 mm的细棒以及3.5 mm的PEEK棒固定后,在前屈、后伸、侧弯和旋转方向上均显著减小了固定节段的运动范围(P<0.05)。直径3.5 mm和2.0 mm的棒固定后的运动范围,在各个方向上无显著性差异。PEEK棒固定的运动范围仅在侧弯方向上大于坚强固定(P=0.005),其他方向无显著性差异。3种固定方式在屈伸、侧弯和旋转方向上均显著减小了固定节段的中性区(P<0.05)。各种固定方式之间相比较,无显著性差异(P>0.05)。结论在寰枢关节采用直径2.0 mm的细棒固定,与坚强固定的稳定性相当。采用直径3.5 mm的PEEK棒固定,在前屈、后伸、旋转方向上与坚强固定的稳定性相当,在侧弯方向上弱于坚强固定。 相似文献
6.
7.
Qian Zhang Larry D. Mesner Gina M. Calabrese Naomi Dirckx Zhu Li Angela Verardo Qian Yang Robert J. Tower Marie-Claude Faugere Charles R. Farber Thomas L. Clemens 《The Journal of clinical investigation》2021,131(7)
Bone mineral density (BMD) is a highly heritable predictor of osteoporotic fracture. GWAS have identified hundreds of loci influencing BMD, but few have been functionally analyzed. In this study, we show that SNPs within a BMD locus on chromosome 14q32.32 alter splicing and expression of PAR-1a/microtubule affinity regulating kinase 3 (MARK3), a conserved serine/threonine kinase known to regulate bioenergetics, cell division, and polarity. Mice lacking Mark3 either globally or selectively in osteoblasts have increased bone mass at maturity. RNA profiling from Mark3-deficient osteoblasts suggested changes in the expression of components of the Notch signaling pathway. Mark3-deficient osteoblasts exhibited greater matrix mineralization compared with controls that was accompanied by reduced Jag1/Hes1 expression and diminished downstream JNK signaling. Overexpression of Jag1 in Mark3-deficient osteoblasts both in vitro and in vivo normalized mineralization capacity and bone mass, respectively. Together, these findings reveal a mechanism whereby genetically regulated alterations in Mark3 expression perturb cell signaling in osteoblasts to influence bone mass. 相似文献
8.
9.
10.
Yuxiang Ma Wenfeng Fang Hongyun Zhao Sai Praneeth Bathena Amol Tendolkar Jennifer Sheng Li Zhang 《The oncologist》2021,26(4):e549-e566
Lessons Learned
- The overall safety profiles of ipilimumab 3 mg/kg and 10 mg/kg administered every 3 weeks, were consistent between Chinese patients with solid tumors in the current study and patients from previous U.S. ipilimumab monotherapy studies. No new safety signals were identified.
- The mean systemic exposures to ipilimumab (assessed by first dose area under the curve during the dosing interval and maximum serum concentration) were numerically lower in the Chinese patient population than in U.S. patients for both 3 mg/kg and 10 mg/kg doses; however, the range of serum concentrations in the Chinese and U.S. populations overlapped (3 mg/kg and 10 mg/kg), suggesting that ipilimumab pharmacokinetics was ethnically insensitive in this study.